510(k) K211438
K211438 is an FDA 510(k) premarket notification submitted by Biosense Webster, Inc. for the device "OPTRELL Mapping Catheter with TRUEref Technology". The FDA issued a decision of Substantially Equivalent on Mar 18, 2022. The device falls under product code MTD (Catheter, Intracardiac Mapping, High-Density Array), a Class II device regulated under 21 CFR 870.1220. Biosense Webster, Inc. has 75 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 18, 2022
- Date Received
- May 10, 2021
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Catheter, Intracardiac Mapping, High-Density Array
- Device Class
- Class II
- Regulation Number
- 870.1220
- Review Panel
- CV
- Submission Type
- 510(k)
Need the full FDA record for Biosense Webster, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.